FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. (“GTC”, Nasdaq: GTCB) reported today its financial results for the first quarter ended April 1, 2007. The total net loss for the quarter was $7.5 million, or $0.10 per share, compared with $8.5 million, or $0.14 per share, in the first quarter of 2006.
